ABOUT THE BOOK

Title: Probiotics and the Human Microbiome: Precision Medicine and Therapeutic Frontiers

Editors: Khushwant Nandal, Dr. Surender Jangra, Dr. Sarita Srivastava, Dr. Manjeet Kaur
Published by: SAAR Publications [Reg.]
Publisher’s Address: A-09, Sita Ram Colony, Balkeshwar, Agra, Uttar Pradesh – 282004
Language: English
Pages: 270
Edition: July 2025
ISBN: 978-81-990154-5-6
DOI: 10.21276/saar/9788199015456
Citation: Nandal, K., Jangra, S., Srivastava, S., & Kaur, M. (2025). Probiotics and the Human Microbiome:  Precision Medicine and Therapeutic Frontiers. https://doi.org/10.21276/saar/9788199015456

In an era where the intricacies of human health are increasingly illuminated through the lens of microscopic ecosystems, the human microbiome stands as a profound testament to our symbiotic existence with trillions of microorganisms. Often dubbed the “forgotten organ” or “second genome,” this dynamic community of bacteria, viruses, fungi, and archaea not only inhabits our bodies but profoundly shapes our physiology, from digestion and immunity to metabolism and even mental well-being. Disruptions in this delicate balance, known as dysbiosis, have been implicated in a cascade of modern ailments, including obesity, autoimmune diseases, neurological disorders, and more. Yet, within this complexity lies immense therapeutic promise: probiotics, beneficial microbes capable of restoring harmony and unlocking personalized health interventions. This book, Probiotics and the Human Microbiome: Precision Medicine and Therapeutic Frontiers, emerges from a convergence of cutting-edge research and clinical insights, aiming to bridge the gap between foundational science and practical applications. Drawing from diverse fields such as microbiology, immunology, genomics, and clinical medicine, it seeks to unravel the structure, function, and diversity of the human microbiome across body sites, while exploring the factors that influence it, the interactions that sustain it, and the consequences of its imbalance. We delve into the mechanisms by which probiotics combat dysbiosis, highlighting their roles in immune modulation, barrier integrity, and disease prevention. Advanced tools like metagenomics, metabolomics, and organoid models are discussed, alongside emerging strategies such as next-generation probiotics and fecal microbiota transplantation. The journey of writing this volume was inspired by the rapid evolution of microbiome science, driven by technological advancements that have transformed our understanding from vague associations to precise, actionable insights. It is particularly timely in the era of precision medicine, where tailoring therapies to individual microbial profiles could revolutionize disease management ranging from inflammatory bowel diseases to neurological conditions. However, challenges persist, including interindividual variability, regulatory hurdles, and the need for rigorous longitudinal studies. This book addresses these challenges, offering a roadmap for future directions, including underexplored niches like the placental microbiome and personalized microbial interventions. Intended for researchers, clinicians, students, and health enthusiasts alike, these pages invite you to explore the frontiers of microbiome therapeutics. May this work spark curiosity, foster innovation, and contribute to a healthier future where we harness our inner ecosystems to advance human well-being. With gratitude to the scientific community whose discoveries continue to light the path

Khushwant is a Research Scholar at Maharshi Dayanand University (MDU), Rohtak, specializing in fermented foods, prebiotics, and microbial applications. With over five years of experience in molecular biology, virology, and bioinformatics, he holds a Master’s degree in Microbial Biotechnology (2019) and a B.Sc. (2017) from MDU. He has worked as a Senior Research Fellow at ICAR–National Research Centre on Equines, where he contributed to a NASF-funded project on antiviral therapeutics, utilizing CRISPR-Cas9, Real-Time PCR, and primary cell culture. Previously, he served at PGIMS, Rohtak and the Central University of Haryana, gaining hands-on experience in diagnostic virology, protein purification, and in-silico analysis. His research blends strong laboratory expertise with computational tools to address challenges in health and biotechnology.

Dr. Surender Jangra holds a Ph.D. in Animal Biochemistry from ICAR–NDRI, Karnal, and an M.Sc. in Biotechnology from CCS HAU, Hisar. He has over six years of teaching and two years of postdoctoral research experience. His work focuses on functional foods and their role in managing non-communicable diseases. Dr. Jangra has published 12 research articles, 4 book chapters, and serves as a reviewer for reputed journals (h-index: 7; 259 citations). He was awarded the Best Poster Award at the XII Agricultural Science Congress in 2015.

Dr. Sarita Srivastava is an Associate Professor of Biochemistry at Galgotias University, Greater Noida. She earned her Ph.D. from Banaras Hindu University, focusing on oxidative stress and metabolic changes in rice under manganese toxicity. With rich teaching experience, her research spans plant stress physiology, nanobiotechnology, and sustainable development. Dr. Srivastava has published in peer-reviewed journals, contributed to book chapters, and actively participates in academic events and student mentoring

Dr. Manjeet Kaur is a faculty member at UIET, MDU Rohtak, with over 17 years of experience in teaching and research. Her work focuses on industrial microbiology, probiotics, gut microbiota, and environmental biotechnology. She has published extensively on topics like microbial enzymes, nanoparticle synthesis, and sustainable solutions such as bioethanol and plastic waste management. Dr. Kaur also explores the role of microbiota in health and traditional medicine

TABLE OF CONTENTS

S.No. Chapter 1. Unravelling Structure, Function and Diversity of Human Microbiome Page No.
1.0 Abstract 1
1.1 Introduction 1
1.2 Composition and Diversity of Human Microbiomes 4
1.3 Factors Affecting Microbiome 6
1.4 Microbial Interactions 7
1.4.1 Microbial Interactions within Microbiome 7
1.4.2 Host-Microbiome Interactions 9
1.5 Dysbiosis and its Associated Disorders 10
1.6 Role of Probiotics in Restoring Microbial Balance: Potential Mechanisms of Action 12
1.7 Research Tools to Study Microbial Dynamics 14
1.8 Challenges and Future Directions 16
1.9 Conclusion 17
References 18
Chapter 2. Strain-Specific Probiotic Mechanisms
2.0 Abstract 28
2.1 Introduction 28
2.2 Probiogenomics: Tool for Gaining Genetic Insights 30
2.3 Functional Adaptations of Probiotics in Gut Health 32
2.4 Probiotic Mechanisms: A Strain-Specific Perspective 34
2.5 Strain-Specificity in Probiotic Therapeutics 36
2.6 Advanced Tools for Studying Strain-Specific Probiotic Mechanisms 39
2.7 Challenges in Strain-Specific Probiotic Research 41
2.8 Future Directions in Personalized Probiotic Therapies 42
2.9 Conclusion 43
References 44
Chapter 3. Host-Microbiota Interactions: Cellular and Molecular Insights
3.0 Abstract 55
3.1 Introduction 55
3.2 Cellular and Molecular Mechanisms of Host-Microbiota Interactions 56
3.2.1 Immune-Microbiota Crosstalk in Gut Homeostasis 56
3.2.2 Intestinal Epithelial Cell-Microbiota Interactions in Gut Homeostasis 58
3.2.3 Mediating Host-Microbiota Crosstalk: The Role of Microbial Metabolites 59
3.2.4 Key Molecular Pathways in Host-Microbiota Interactions 61
3.3 Microbiota Influence on Host Immunity 62
3.4 Microbiota-Host Interactions in Immune and Metabolic Diseases 64
3.5 Therapeutic Potential of Host-Microbiota Interactions in Autoimmune and Metabolic Diseases 65
3.6 Future Directions and Challenges in Microbiome Research 67
3.7 Conclusion 68
References 68
Chapter 4. Probiotic Bioengineering
4.0 Abstract 77
4.1 Introduction to Probiotic Bioengineering 77
4.2 Genetic Engineering of Probiotics for Next-Generation Probiotics 79
4.2.1 Role of CRISPR-Cas9 in Probiotic Gene Editing 79
4.2.2 Transposons and Integrative Vectors in Probiotic Genetic Engineering 80
4.2.3 Genetically Modified Lactobacillus for Lactase Production 81
4.3 Metabolic Engineering of Probiotics for Next-Generation Probiotics 82
4.4 Synthetic Biology Approaches to Probiotic Engineering 83
4.5 Engineering Probiotics for Gut Health Benefits 84
4.5.1 Enhancing Probiotic Adherence and Colonization in the Gut 84
4.5.2 Immune Modulation by Engineered Probiotics 85
4.5.3 Engineered Probiotics for Restoring Microbial Balance 85
4.6 Engineered Probiotics: Innovations in Disease Prevention and Treatment 86
4.6.1 Designing Probiotics for Pathogen Inhibition 86
4.6.2 Engineered Probiotics in Metabolic Disease Management 87
4.6.3 Engineered Probiotics in Cancer Therapy 87
4.7 Probiotic Bioengineering: Addressing Challenges, Ethics, and Public Trust 88
4.8 Future Directions and Prospects 90
4.9 Conclusion 90
References 91
Chapter 5. Emerging Tools and Technologies in Probiotic Research
5.0 Abstract 98
5.1 Introduction 98
5.2 Advancements in Probiotic Research 99
5.2.1 High-Throughput Screening in Probiotic Research 99
5.2.2 Whole-Genome Sequencing in Probiotic Research 100
5.2.3 Omics Approaches in Probiotic Research 101
5.3 Single-Cell Analysis and Advanced Microscopy in Probiotic Research 102
5.4 Metagenomics and Microbiome Profiling: Revolutionizing Probiotic Research 103
5.5 Advanced Culturing Techniques for Probiotic Research 105
5.6 Systems Biology in Probiotic Research 105
5.7 Future Directions and Challenges in Probiotic Research Technologies 106
5.8 Conclusion 107
References 108
Chapter 6. Probiotics as a Tool for Precision Medicine
6.0 Abstract 114
6.1 Introduction 114
6.2 The Gut Microbiome in Personalized Therapeutics 116
6.3 Customizing Probiotics through Individual Genomic Insights 117
6.4 Personalized Probiotics for Chronic Disease Prevention and Management 118
6.5 Microbiome Diagnostics and Personalized Probiotic Interventions 119
6.6 Psychobiotics: Probiotics for Mental and Neurological Health 120
6.7 Advances in Probiotic Formulations for Precision Medicine 121
6.8 Challenges in Integrating Probiotics into Precision Medicine 121
6.9 Future Directions and Innovations in Probiotic Therapies 122
6.10 Conclusion 122
References 123
Chapter 7. Probiotics as Immunotherapeutics in Autoimmune Diseases
7.0 Abstract 129
7.1 Introduction 129
7.2 The Role of Probiotics in Gut-Immune Regulation 131
7.3 Immunomodulatory Roles of Probiotics in Autoimmune and Inflammatory Disorders 132
7.3.1 Probiotics in Rheumatoid Arthritis Management 132
7.3.2 Probiotics and Multiple Sclerosis 133
7.3.3 Probiotics in Inflammatory Bowel Disease 133
7.3.4 Probiotics and Type 1 Diabetes Mellitus 134
7.3.5 Probiotics in Systemic Lupus Erythematosus 135
7.4 How Probiotics Modulate the Immune System: Mechanisms of Action 135
7.5 Probiotics as Adjunct Therapies in Autoimmune Disorders 137
7.6 Current Challenges in Probiotic Use for Autoimmune Conditions 138
7.7 Probiotics in Autoimmune Diseases: Future Directions and Innovations 139
7.8 Conclusion 140
References 141
Chapter 8. The Oncomicrobiome: Therapeutic Potential of Probiotics in Cancer Management
8.0 Abstract 147
8.1 Introduction 147
8.2 Microbiome-Mediated Modulation of Cancer Immunity 150
8.3 Microbial Metabolites and their Role in Tumor Metabolism and Immunity 151
8.4 Probiotics as Supportive Agents in Cancer Therapy 153
8.5 The Role of Probiotics in Cancer Therapy: Mechanisms and Therapeutic Potential 154
8.6 Probiotics and Specific Cancer Types 156
8.6.1 Probiotics in Gastrointestinal Cancers 156
8.6.2 Probiotics in Breast Cancer 158
8.6.3 Probiotics in Lung Cancer 160
8.6.4 Probiotics in Skin Cancer 161
8.7 Probiotics as Adjuncts in Conventional Cancer Therapies: Enhancing Efficacy and Reducing Toxicity 163
8.8 Clinical Evidence and Therapeutic Integration of Probiotics in Cancer Care 165
8.9 Challenges and Limitations of Probiotic Therapy in Cancer 167
8.10 The Future of Probiotics in Cancer Therapy 169
8.11 Conclusion 171
References 172
Chapter 9. Neuroprobiotics and Cognitive Health: Exploring
the Gut-Brain Axis
9.0 Abstract 182
9.1 Introduction 182
9.2 Mechanisms of Action: How Probiotics Influence Cognitive Health 185
9.3 Probiotics and Neurodegenerative Diseases 189
9.3.1 Alzheimer’s Disease 189
9.3.2 Parkinson’s Disease 190
9.3.3 Multiple Sclerosis 192
9.3.4 Other Neurodegenerative Conditions 193
9.4 Probiotics and Mental Health Disorders 194
9.4.1 Depression and Anxiety 194
9.4.2 Stress and Cognitive Decline 195
9.4.3 Autism Spectrum Disorder 196
9.5 Mechanistic Insights into Probiotic-Induced Cognitive Enhancement 198
9.6 Clinical Evidence and Cognitive Outcomes 201
9.7 Factors Influencing Clinical Trial Outcomes 202
9.8 Safety Considerations in Neurological and Immunocompromised Populations 202
9.9 Future Directions and Innovations in Neuroprobiotic Research 203
9.10 Conclusion 206
References 206
Chapter 10. Age-Specific Probiotic Strategies: Pediatric Foundations and Geriatric Innovations
10.0 Abstract 219
10.1 Introduction 219
10.2 Probiotics in Pediatric Health 221
10.2.1 Establishment of the Gut Microbiota in Early Life 221
10.2.2 Role of Probiotics in Shaping Infant Gut Microbiota 221
10.2.3 Probiotics in Pediatric Gastrointestinal Disorders 222
10.2.4 Probiotics and Immune System Development in Infants and Children 223
10.2.5 Probiotics and Gut-Brain Axis in Children 224
10.2.6 Probiotics in Neurodevelopmental and Neuropsychiatric Disorders 225
10.2.7 Probiotics and Pediatric Allergy Prevention 225
10.3 Probiotics in Geriatric Health 227
10.3.1 Gut Microbiota in Aging 227
10.3.2 Probiotics in Enhancing Digestive Health in the Elderly 228
10.3.3 Probiotics and Immune Function in Older Adults 229
10.3.4 Probiotics and Cognitive Health in Aging 230
10.3.5 Optimizing Metabolic Health in Older Adults Through Probiotics 231
10.3.6 Probiotics and Bone Health in Older Adults 232
10.4 Probiotic Use in Vulnerable Age Groups: Pediatric and Geriatric Considerations 233
10.5 Future Directions and Challenges 236
10.6 Conclusion 238
References 238
Glossary 247